missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
STEMCELL Technologies SU5416
Beskrivning
- SU5416 is a tyrosine kinase inhibitor best known as an ATP-competitive inhibitor of the kinase insert domain (KDR/VEGFR2/FLK1)
- In addition to inhibiting KDR (IC50 = 1 μM), SU5416 also inhibits PDGFR (IC50 = 20 μM), KIT (IC50 = 30 nM), RET (IC50 = 170 nM), FLT-3 (IC50 = 160 nM), ABL (IC50 = 11 μM), and ALK (IC50 = 1.2 μM)
- SU5416 does not inhibit EGFR or FGFR tyrosine kinases (IC50 > 100 μM; Fong et al.; Litz; Mologni et al.)
- Prevents angiogenesis, thereby inhibiting tumor growth, catalysis and vascularization for a variety of cancers (Litz; Fong et al.)
- Inhibits RET-mediated transformation of NIH-3T3 mouse fibroblasts and Ba/F3 mouse pro-B cells (Mologni et al.)
- Causes pulmonary hypertension in SuHx rat model of pulmonary arterial hypertension, when combined with hypoxia (de Raaf et al.; Mizuno et al.)
- Inhibits TGFβ1 activation and delays wound healing in rats (Haroon et al.)
Specifikationer
Specifikationer
| CAS | 204005-46-9 |
| Synonym | NSC 696819; Semaxinib; Sugen 5416; VEGFR 2 Kinase Inhibitor |
| Kvantitet | 10 mg |
| Molekylformel | C15H14N2O |
| Renhet | ≥98% |
Produkttitel
Genom att klicka på Skicka bekräftar du att du kan bli kontaktad av Fisher Scientific angående feedbacken du har lämnat i detta formulär. Vi kommer inte att dela din information för andra ändamål. All kontaktinformation som tillhandahålls ska också underhållas i enlighet med vår Sekretesspolicy.
Hittar du en möjlighet till förbättring?